A number of studies have uncovered an essential role for BRD4 in various malignancies including Myc-driven cancers [28, 29], leukemia [30, 31], lymphoma [32], lung adenocarcinoma [33], prostate [34] and breast cancers [10, 35, 36]. This evidence concerns the gene BRD4 and lymphoma.